TeselaGen Biotechnology launches a cutting-edge Electronic Lab Notebook (ELN) and enhanced user interface to streamline workflows and boost collaboration. Fully integrated with TeselaGen’s platform, the ELN offers real-time collaboration, secure data management, and intuitive navigation.
TeselaGen Biotechnology, Inc., a leader in biological design and process automation, has announced the launch of its spin-off, Built Biotechnologies, Inc., to revolutionize DNA manufacturing. Specializing in advanced DNA workflows crucial for cell and gene therapies and other biotech sectors, Built addresses the challenge of constructing complex DNA molecules, essential for advancing synthetic biology.
TeselaGen Biotechnology Inc. announces the acquisition of two cutting-edge patents that advance AI-driven optimization of biological phenotypes. These additions fortify the company’s intellectual property, emphasizing its dedication to revolutionizing the biotech industry. CEO Eduardo Abeliuk states that these patents mark a significant milestone for TeselaGen, highlighting the role of AI in streamlining biotech product development. The company’s collaborations with pioneering biotech firms underscore its commitment to innovation and industry advancement.
TeselaGen Biotechnology and the Joint BioEnergy Institute (JBEI) have renewed their partnership through 2027, aiming to revolutionize carbon-neutral bioproducts production. By merging innovative technology with groundbreaking biofuel research, this collaboration is driving sustainability and ecological balance in the biotechnology sector.
The homology path software integration enables researchers to design oligo assembly reactions, automate the reaction setup, order the needed DNA, and integrate with lab automation, all within a single platform
“TeselaGen has saved us countless hours throughout our DNA assembly design process and enabled us to perform high-throughput DNA library construction. In addition, their user interface is intuitive, and their customer support has been exceptional. We have been able to make it easy for us to train new team members and get them using the software productively,” added Kobe Rogers, COO of Ourobio.
TeselaGen Biotechnology announced today the release of its Starter Edition for small groups, a convenient, cloud-based software platform that offers small groups in academia and
TeselaGen Biotechnology announced today the release of its Community Edition, a powerful, easy-to-use version of its popular Design Module within the TeselaGen® Operating System for biotechnology. The free, cloud-based software gives access to previously unavailable tools for designing DNA constructs.
TeselaGen Biotechnology announced today a two-year contract with BioMADE, the Department of Defense-sponsored bioindustrial Manufacturing Innovation Institute, to improve the informatics infrastructure around fermentation-based biomanufacturing. As part of this collaboration, TeselaGen will develop novel technologies that standardize data exchange, connect disparate software systems, and establish secure protocols to facilitate collaboration on AI-enabled projects.
TeselaGen Biotechnology announced today that it has partnered with the iGEM Foundation to support the iGEM Design League, a new competition that aims to advance synthetic biology, starting with Latin America. As part of the collaboration, students will have access to the TeselaGen® operating system for biotechnology to design projects that solve critical local problems using synthetic biology.